Teixeira, M.I.; Lopes, C.M.; Gonçalves, H.; Catita, J.; Silva, A.M.; Rodrigues, F.; Amaral, M.H.; Costa, P.C.
Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain. Pharmaceutics 2022, 14, 185.
https://doi.org/10.3390/pharmaceutics14010185
AMA Style
Teixeira MI, Lopes CM, Gonçalves H, Catita J, Silva AM, Rodrigues F, Amaral MH, Costa PC.
Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain. Pharmaceutics. 2022; 14(1):185.
https://doi.org/10.3390/pharmaceutics14010185
Chicago/Turabian Style
Teixeira, Maria Inês, Carla Martins Lopes, Hugo Gonçalves, José Catita, Ana Margarida Silva, Francisca Rodrigues, Maria Helena Amaral, and Paulo C. Costa.
2022. "Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain" Pharmaceutics 14, no. 1: 185.
https://doi.org/10.3390/pharmaceutics14010185
APA Style
Teixeira, M. I., Lopes, C. M., Gonçalves, H., Catita, J., Silva, A. M., Rodrigues, F., Amaral, M. H., & Costa, P. C.
(2022). Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain. Pharmaceutics, 14(1), 185.
https://doi.org/10.3390/pharmaceutics14010185
